Literature DB >> 23022960

Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma.

Samar A Hegazy1, Abdulraheem Alshareef, Pascal Gelebart, Mona Anand, Hanan Armanious, Robert J Ingham, Raymond Lai.   

Abstract

Our previous oligonucleotide array studies revealed that ALK-positive anaplastic large cell lymphoma (ALK(+)ALCL) express high levels of the disheveled proteins (Dvls), a family of proteins that is integral to the Wnt signaling pathways. In this study, we assessed whether the Dvls are important in the pathogenesis of ALK(+)ALCL. By Western blotting, Dvl-2 and Dvl-3 were found to be highly expressed in ALK(+)ALCL cell lines and patient samples. The higher molecular weight forms, consistent with phosphorylated/active Dvl proteins, were observed in these lysates. siRNA knock-down of Dvls did not affect the Wnt canonical pathway, as assessed by the β-catenin protein levels and nuclear localization. In contrast, the same treatment led to changes in the transcriptional activity of NFAT and the phosphorylation status of Src, both of which are known to be regulated by the Wnt non-canonical signaling pathways in other cell types. Coupled with these biochemical changes, there was a significant decrease in cell growth and soft agar colony formation. NPM-ALK, the oncogenic tyrosine kinase characteristic of ALK(+)ALCL, was found to bind to the Dvls and enhance their tyrosine phosphorylation. In conclusion, our data suggest that the Dvls contribute to the pathogenesis of ALK(+)ALCL via signaling in the Wnt non-canonical pathways. To our knowledge, this is the first report demonstrating a physical and functional interaction between the Dvls and an oncogenic tyrosine kinase.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23022960     DOI: 10.1016/j.cellsig.2012.09.027

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  4 in total

Review 1.  Wnt Signaling in Hematological Malignancies.

Authors:  Stephanie Grainger; David Traver; Karl Willert
Journal:  Prog Mol Biol Transl Sci       Date:  2017-12-29       Impact factor: 3.622

2.  The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers.

Authors:  Abdulraheem Alshareef; Hai-Feng Zhang; Yung-Hsing Huang; Chengsheng Wu; Jing Dong Zhang; Peng Wang; Ahmed El-Sehemy; Mohamed Fares; Raymond Lai
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

3.  β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.

Authors:  Annalen Bleckmann; Lena-Christin Conradi; Kerstin Menck; Nadine Annette Schmick; Antonia Schubert; Eva Rietkötter; Jetcy Arackal; Peter Middel; Alexandra Schambony; Torsten Liersch; Kia Homayounfar; Tim Beißbarth; Florian Klemm; Claudia Binder; Tobias Pukrop
Journal:  Clin Exp Metastasis       Date:  2016-02-09       Impact factor: 5.150

4.  Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses.

Authors:  Julien Broséus; Gaili Chen; Sébastien Hergalant; Gérard Ramstein; Nicolas Mounier; Jean-Louis Guéant; Pierre Feugier; Christian Gisselbrecht; Catherine Thieblemont; Rémi Houlgatte
Journal:  Oncotarget       Date:  2016-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.